Search results
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 47 minutes agoBut that beat projections for a loss of $3.56 per share. Moderna says the European Union is planning...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 6 hours agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 9 hours agoModerna stock soared on Wednesday after its first-quarter earnings report sailed past Wall Street’s...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 6 hours agoMuch of Moderna’s focus is on nabbing FDA approval for a respiratory syncytial virus vaccine, a...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 10 hours agoA Food and Drug Administration decision on approval of Moderna’s RSV vaccine is expected by May 12,...
Moderna (MRNA) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 4 hours agoThe 10 stocks that made the cut could produce monster returns...with an easy-to-follow blueprint for success, including guidance on building a portfolio,...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 10 hours agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 6 hours agoManagement expects to record around...0.9 billion and end 2024 with a cash balance of around $9...
Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.
Barrons.com· 6 hours agoModerna reported first-quarter financial results Thursday that soundly beat Wall Street...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline
Guru Focus· 14 hours agoOn May 2, 2024, Moderna Inc (MRNA, Financial) released its 8-K filing, disclosing a challenging first quarter with total revenues of $167 million, a stark decline from $1.9 ...
